Trial Search Results

Endurant Stent Graft System Post Approval Study (ENGAGE PAS)

The purpose of the study is to demonstrate the long term safety and effectiveness of the Endurant Stent Graft System for the endovascular treatment of infrarenal abdominal aortic aneurysms in a post-approval environment, through the endpoints established in this protocol.

The clinical objective of the study is to evaluate the long term safety and effectiveness of the Endurant Stent Graft System assessed at 5 years through freedom from Aneurysm-Related Mortality (ARM).

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Medtronic Cardiovascular

Collaborator: Duke Clinical Research Institute

Stanford Investigator(s):


  • Device: Endurant Stent Graft System




Inclusion Criteria:

   - Age ≥18 years

   - Indication for elective surgical repair of abdominal aortic aneurysm (AAA) with an
   endovascular stent graft in accordance with the applicable guidelines on endovascular
   interventions and the Instructions for Use of the Endurant Stent Graft System

   - Signed consent form. The subject or legal representative has been informed of the
   nature of the trial and has consented to participate and authorized the collection and
   release of his medical information

   - Intention to electively implant the Endurant Stent Graft System

   - Ability and willingness to comply with the Clinical Investigational Plan (CIP).

Exclusion Criteria:

   - High probability of non-adherence to physician's follow-up requirements

   - Current participation in a concurrent trial which may confound study results

   - Female of childbearing potential in whom pregnancy cannot be excluded or who is

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Ronald Dalman
Not Recruiting